May 06, 2020 / 08:30PM GMT
Operator
Hello, and welcome to Ligand's First Quarter of 2020 Financial Results and Business Update Conference Call. My name is Catherine, and I will be your event specialist today. (Operator Instructions) And please note that today's webcast is being recorded. (Operator Instructions)
It is now my pleasure to turn today's program over to Patrick O'Brien, SVP, Investor Relations at Ligand's Pharmaceuticals. Patrick, the floor is yours.
Patrick O'Brien - Ligand Pharmaceuticals Incorporated - SVP of IR
Thank you, Catherine, and welcome, everyone. Consistent with recommendations for social distancing, all of our speakers for today's call are in separate locations. So we apologize in advance for any background noise or technology difficulties that we might run into.
Speaking for Ligand today will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will be using slides to guide our discussion today. We will also use non-GAAP financial measures, and some of our statements will be forward-looking.
Additional
Q1 2020 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers